Atara Biotherapeutics, Inc. Annual Costs and Expenses in USD from 2022 to 2024

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Atara Biotherapeutics, Inc. quarterly/annual Costs and Expenses history and growth rate from 2022 to 2024.
  • Atara Biotherapeutics, Inc. Costs and Expenses for the quarter ending December 31, 2024 was $45M, a 30% decline year-over-year.
  • Atara Biotherapeutics, Inc. Costs and Expenses for the twelve months ending December 31, 2024 was $212M, a 25.4% decline year-over-year.
  • Atara Biotherapeutics, Inc. annual Costs and Expenses for 2024 was $212M, a 25.4% decline from 2023.
  • Atara Biotherapeutics, Inc. annual Costs and Expenses for 2023 was $285M, a 17.3% decline from 2022.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Annual (USD)
Costs and Expenses, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $212M -$72.2M -25.4% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-07
2023 $285M -$59.5M -17.3% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-07
2022 $344M Jan 1, 2022 Dec 31, 2022 10-K 2024-03-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.